title: Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin.
abstract: Candida krusei infections are serious complications in neutropenic patients with hematological malignancies. We report the successful treatment of C. krusei infection with caspofungin in 3 allogeneic hematopoietic stem cell transplant recipients and 1 patient with induction chemotherapy for acute myeloid leukemia.
authors.affiliation: Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Conen
authors.forename: M
authors.initials: M
authors.lastname: Weisser
authors.forename: C Orasch
authors.initials: CO
authors.lastname: Jörg
authors.forename: M
authors.initials: M
authors.lastname: Battegay
authors.forename: A
authors.initials: A
authors.lastname: Trampuz
authors.forename: R
authors.initials: R
authors.lastname: Frei
authors.forename: S
authors.initials: S
authors.lastname: Christen
authors.forename: D
authors.initials: D
authors.lastname: Heim
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
authors.forename: U
authors.initials: U
authors.lastname: Flückiger
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000145:classification / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D054714:Echinocandins / Q000627:therapeutic use*; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D055666:Lipopeptides; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications; D014184:Transplantation, Homologous / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin